SCHEMBL8417628

SCHEMBL8417628

c1ccc(-c2c(-c3ccccc3)n(CCCCN3CCN(c4ncccn4)CC3)c3ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.51
DRD3 P35462 5/20 0.49
ALDH1A1 P00352 2/20 0.46
TSHR P16473 1/20 0.46
DRD2 P14416 6/20 0.46
HTR2A P28223 5/20 0.46
HTR7 P34969 5/20 0.46
DRD4 P21917 3/20 0.46
DRD1 P21728 1/20 0.46
DRD5 P21918 1/20 0.46
HTR6 P50406 3/20 0.45
ADRA2A P08913 2/20 0.45
ADRA2C P18825 2/20 0.45
ADRA1A P35348 2/20 0.45
ABCB11 O95342 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA1D P25100 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8417646 0.76 SOAT1 (0.49) HTR1ADRD3ALDH1A1TSHRDRD2
SCHEMBL8417626 0.75 FAAH (0.51) HTR1ADRD3ALDH1A1TSHRDRD2
SCHEMBL8418007 0.73 HTR1A (0.54) HTR1ADRD3ALDH1A1DRD2HTR2A
SCHEMBL8419683 0.73 PRKD3 (0.54) HTR1ADRD3ALDH1A1TSHRDRD2
SCHEMBL8416338 0.73 P2RX7 (0.63) HTR1ADRD3DRD2HTR2AHTR7
SCHEMBL8418064 0.72 HTR1A (0.59) HTR1ADRD3DRD2HTR2AHTR7
SCHEMBL26108581 0.72 HTR1A (0.65) HTR1ADRD3ALDH1A1DRD2HTR2A
SCHEMBL26492991 0.72 HTR1A (0.65) HTR1ADRD3ALDH1A1DRD2HTR2A
SCHEMBL6562979 0.72 ALDH1A1 (0.62) ALDH1A1TSHR
SCHEMBL10629294 0.71 HTR1A (0.52) HTR1ADRD3ALDH1A1DRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed